Analyst Price Targets — ARGX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 7, 2026 11:27 am | — | RBC Capital | $945.00 | $916.80 | TheFly | Argenx price target raised to $945 from $890 at RBC Capital |
| June 24, 2026 1:37 pm | Luca Issi | RBC Capital | $890.00 | $855.84 | StreetInsider | RBC Capital on argenx SE (ARGX): 'We Are Buyers On Myositis Stock Weakness' |
| June 24, 2026 12:12 pm | Sean Laaman | Morgan Stanley | $1,180.00 | $869.41 | TheFly | Argenx price target raised to $1,180 from $1,170 at Morgan Stanley |
| June 4, 2026 10:40 am | Douglas Tsao | H.C. Wainwright | $940.00 | $813.14 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on argenx SE (ARGX) |
| June 1, 2026 10:38 am | — | Wells Fargo | $1,291.00 | $835.99 | TheFly | Argenx price target raised to $1,291 from $1,260 at Wells Fargo |
| May 28, 2026 8:07 pm | Alex Thompson | Stifel Nicolaus | $1,255.00 | $838.49 | StreetInsider | argenx SE (ARGX) PT Raised to $1,255 at Stifel |
| May 8, 2026 1:08 pm | Sean Laaman | Morgan Stanley | $1,170.00 | $788.73 | TheFly | Argenx price target lowered to $1,170 from $1,230 at Morgan Stanley |
| May 8, 2026 11:13 am | Yatin Suneja | Guggenheim | $1,135.00 | $787.31 | TheFly | Argenx price target raised to $1,135 from $1,120 at Guggenheim |
| May 8, 2026 10:24 am | — | Wells Fargo | $1,260.00 | $787.31 | TheFly | Argenx price target raised to $1,260 from $1,247 at Wells Fargo |
| May 7, 2026 3:00 pm | — | Stifel Nicolaus | $1,222.00 | $784.96 | TheFly | Argenx price target lowered to $1,222 from $1,227 at Stifel |
Latest News for ARGX
Artisan Mid Cap Fund portfolio generated strong absolute returns and outpaced the Russell Midcap® Growth Index. Within IT, several semiconductor holdings produced exceptional returns, with multiple positions rising more than 100% during the period. During the quarter, we initiated new positions in Entegris, Modine Manufacturing and C.H. Robinson Worldwide.
SAN FRANCISCO--(BUSINESS WIRE)--Chai Discovery, the AI company building a computer-aided design suite for molecules, today announced a collaboration agreement with argenx, a leading immunology innovation company. The collaboration will see argenx get access to Chai's AI platform and apply de novo antibody discovery across therapeutic targets. argenx has built one of biotechnology's most productive antibody engines,…
Here is how argenex SE (ARGX) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Fortrea Holdings Inc. (FTRE) and argenex SE (ARGX). But which of these two stocks offers value investors a better bang for their buck right now?
This profitable Netherlands-based biotech name has produced triple-digit quarterly earnings growth.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for ARGX.
Senate Trading
No Senate trades found for ARGX.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.